Reduced Level of CD44 and Hyaluronan Associated with Unfavorable Prognosis in Clinical Stage I Cutaneous Melanoma
- 1 September 2000
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 157 (3) , 957-965
- https://doi.org/10.1016/s0002-9440(10)64608-1
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Melanoma epidemiologyCurrent Opinion in Oncology, 1997
- CD44 expression in melanocytic lesions: a marker of malignant progression?British Journal of Dermatology, 1996
- CD44 phosphorylation regulates melanoma cell and fibroblast migration on, but not attachment to, a hyaluronan substratumCurrent Biology, 1996
- Expression of CD44 isoforms in human skin cancerEuropean Journal Of Cancer, 1996
- Restoration of CD44H Expression in Colon Carcinomas Reduces TumorigenicityAnnals of Surgery, 1995
- Glycoconjugate profile and cd44 expression in human melanoma cell lines with different metastatic capacityInternational Journal of Cancer, 1995
- Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development.The Journal of Experimental Medicine, 1994
- Migration of Human Melanoma Cells on Hyaluronate Is Related to CD44 ExpressionJournal of Investigative Dermatology, 1993
- Cutaneous melanoma: Prognosis and treatment results worldwideSeminars in Surgical Oncology, 1992
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958